Similarly, CCL21, which has been described to enhance the recruitment of immune cells in the tumor and to participate to the establishment of a potent immune cellular response (40–42), is significantly reduced in the tumor microenvironment compared to the adjacent tissue. The gene discussed is CCL21; the disease is neoplasm.